Xin Li et al.
FULL PAPERS
MS (EI+): m/z=406.1088, calcd. for [C23H19N2O3Cl]:
406.1084. The enantiomeric excess was determined by
HPLC with an AD-H column at 210 nm (2-propanol:hex-
at 210 nm (2-propanol:hexane=1:4), 1.0 mLminÀ1
; tR =
8.7 min (minor), 9.8 min (major).
Compound 15: The Michael product was synthesized ac-
cording to the general procedure as a white solid; overall
yield: 91%. [a]D25: À15.08 (c 1.0, CHCl3); 1H NMR
(300 MHz, CDCl3): d=7.45–7.33 (m, 3H), 7.27–7.12 (m,
3H), 6.95 (d, J=7.68 Hz, 2H), 6.67–6.58 (m, 2H), 6.41–6.34
(m, 2H), 5.86 (d, J=5.69 Hz, 2H), 5.11–5.06 (m, 1H), 4.89
(t, J=12.60 Hz, 1H), 4.00 (dd, J=4.39, 11.25 Hz, 1H), 1.61
(s, 3H); 13C NMR (CDCl3, 75 MHz): d=177.47, 147.47,
147.31, 143.72, 133.85, 130.18, 129.59, 128.95, 128.34, 128.27,
126.41, 123.65, 123.04, 122.71, 109.76, 108.95, 107.91, 101.06,
76.31, 50.90, 50.35, 20.81; HR-MS (EI+): m/z=416.1375,
calcd. for [C24H20N2O5]: 416.1372. The enantiomeric excess
was determined by HPLC with an AD-H column at 210 nm
ane=1:4), 1.0 mLminÀ1
; tR =13.2 min (minor), 27.9 min
(major).
Compound 11: The Michael product was synthesized ac-
cording to the general procedure as a white solid; overall
yield: 95%. [a]D25: +72.08 (c 0.5, CHCl3); 1H NMR
(300 MHz, CDCl3): d=7.46–7.41 (m, 2H), 7.36–7.30 (m,
3H), 7.21–7.13 (m, 5H), 7.05–6.97 (m, 2H), 6.71 (d, J=
7.68 Hz, 1H), 4.84–4.79 (m, 3H), 1.41 (s, 3H); 13C NMR
(CDCl3, 75 MHz): d=177.50, 143.13, 136.42, 133.94, 133.37,
131.44, 130.05, 129.71, 129.33, 128.89, 128.36, 126.82, 126.51,
126.24, 123.59, 123.50, 109.69, 75.76, 49.57, 44.32, 20.87; HR-
MS (EI+): m/z=406.1087, calcd. for [C23H19N2O3Cl]:
406.1084. The enantiomeric excess was determined by
HPLC with an AD-H column at 210 nm (2-propanol:hex-
(2-propanol:hexane=1:4),
1.0 mLminÀ1
;
tR =13.9 min
(minor), 36.2 min (major).
Compound 16: The Michael product was synthesized ac-
ane=1:4), 1.0 mLminÀ1
;
tR =7.3 min (minor), 8.0 min
(major).
cording to the general procedure as a white solid; overall
1
Compound 12: The Michael product was synthesized ac-
cording to the general procedure as a white solid; overall
yield: 98%. [a]D25: +92.38 (c 1.0, CHCl3); 1H NMR
(300 MHz, CDCl3): d=7.60–7.40 (m, 5H), 7.32–7.23 (m,
4H), 7.20–7.03 (m, 3H), 6.80 (d, J=7.96 Hz, 1H), 4.92–4.82
(m, 3H), 1.48 (s, 3H); 13C NMR (CDCl3, 75 MHz): d=
177.62, 143.13, 135.10, 133.99, 133.45, 131.61, 129.74, 129.65,
129.07, 128.89, 128.40, 128.40, 127.91, 127.56, 126.55, 123.74,
123.57, 109.70, 75.86, 49.56, 47.10, 20.93; HR-MS (EI+):
m/z=450.0584 and 452.0561, calcd. for [C23H19BrN2O3]:
450.0579 and 452.0559. The enantiomeric excess was deter-
mined by HPLC with an OD-H column at 210 nm (2-propa-
yield: 92%. [a]2D5: À8.08 (c 1.0, CHCl3); H NMR (300 MHz,
CDCl3): d=8.01 (d, J=8.51 Hz, 2H), 7.43–7.34 (m, 3H),
7.30–7.26 (m, 2H), 7.23–7.18 (m, 1H), 7.10 (d, J=8.51 Hz,
2H), 6.82 (d, J=7.14 Hz, 2H), 6.65 (d, J=7.68 Hz, 1H),
5.17–5.11 (m, 1H), 5.00 (t, J=12.90 Hz, 1H), 4.22 (dd, J=
4.39, 11.25 Hz, 1H), 1.66 (s, 3H); 13C NMR (CDCl3,
75 MHz): d=176.77, 147.80, 143.46, 142.23, 133.35, 129.93,
129.72, 129.47, 129.21, 128.53, 125.99, 123.59, 123.48, 123.19,
110.16, 75.52, 50.66, 50.23, 21.12. The enantiomeric excess
was determined by HPLC with an AD-H column at 210 nm
(2-propanol:hexane=1:4),
1.0 mLminÀ1
;
tR =24.6 min
(minor), 45.2 min (major).
Compound 17: The Michael product was synthesized ac-
nol:hexane=1:9), 1.0 mLminÀ1
;
tR =12.3 min (minor),
31.9 min (major).
cording to the general procedure as a white solid; overall
1
Compound 13: The Michael product was synthesized ac-
cording to the general procedure as a white solid; overall
yield: 90%. [a]D25: À23.08 (c 1.0, CHCl3); 1H NMR
(300 MHz, CDCl3): d=7.51–7.48 (m, 2H), 7.44–7.40 (m,
2H), 7.36–7.30 (m, 6H), 7.27–7.22 (m, 2H), 7.20–7.15 (m,
1H,), 6.89 (d, J=7.96 Hz, 2H), 6.76–6.73 (m, 2H), 6.55 (d,
J=7.68 Hz, 1H), 5.22–5.16 (m, 1H), 5.02 (t, J=12.90 Hz,
1H), 4.14 (dd, J=4.67, 11.25 Hz, 1H), 1.69 (s, 3H, s);
13C NMR (CDCl3, 75 MHz): d=177.36, 143.98, 141.25,
140.52, 133.72, 133.67, 129.87, 129.54, 128.17, 128.98, 128.81,
128.28, 127.46, 127.01, 126.81, 126.51, 123.71, 122.99, 109.75,
76.04, 51.18, 50.41, 20.53; HR-MS (EI+): m/z=448.1791,
calcd. for [C29H24N2O3]: The enantiomeric excess was deter-
mined by HPLC with an AD-H column at 210 nm (2-propa-
yield: 94%. [a]25: +448 (c 1.0, CHCl3); H NMR (300 MHz,
CDCl3): d=8.1D1 (td, J=1.92, 7.41 Hz, 1H), 7.65 (s, 1H),
7.44–7.35 (m, 5H), 7.33–7.21 (m, 3H), 6.82 (d, J=7.14 Hz,
2H), 6.65–6.62 (m, 1H), 5.17–5.11 (m, 1H), 5.05–4.97 (m,
1H), 4.23 (dd, J=4.39, 11.25 Hz, 1H), 1.66 (s, 3H);
13C NMR (CDCl3, 75 MHz): d=176.85, 147.76, 143.36,
137.07, 135.94, 133.38, 129.70, 129.57, 129.14, 128.48, 126.06,
123.61, 123.29, 122.98, 110.10, 75.59, 50.63, 50.13, 21.03. The
enantiomeric excess was determined by HPLC with an AD-
H
column
at
210 nm
(2-propanol:hexane=1:4),
1.0 mLminÀ1; tR =13.0 min (minor), 29.5 min (major).
Compound 18: The Michael product was synthesized ac-
cording to the general procedure as colorless oil; overall
yield: 95%. [a]D25: +53.28 (c 1.0, CHCl3); 1H NMR
(300 MHz, CDCl3): d=7.57–7.52 (m, 2H), 7.46–7.37 (m,
3H), 7.29–7.19 (m, 5H), 7.14–7.10 (m, 2H), 6.85 (d, J=
7.68 Hz, 1H), 4.65–4.59 (m, 1H), 4.49–4.42 (m, 1H), 3.05–
2.97 (m, 1H), 2.71–2.54 (m, 2H), 2.06–1.95 (m, 1H), 1.77–
1.64 (m, 1H), 1.54 (s, 3H); 13C NMR (CDCl3, 75 MHz): d=
178.14, 143.16, 140.95, 134.13, 131.43, 129.71, 128.64, 128.52,
128.32, 126.51, 126.20, 123.42, 109.91, 49.96, 44.04, 33.98,
30.92, 22.19; HR-MS (EI+): m/z=400.1790, calcd. for
[C25H24N2O3]: 400.1787. The enantiomeric excess was deter-
mined by HPLC with an AD-H column at 210 nm (2-propa-
nol:hexane=1:4), 1.0 mLminÀ1
29.3 min (major).
;
tR =14.1 min (minor),
Compound 14: The Michael product was synthesized ac-
cording to the general procedure as a white solid; overall
yield: 97%. [a]D25: À91.68 (c 1.0, CHCl3); 1H NMR
(300 MHz, CDCl3): d=8.22 (d, J=8.51 Hz, 1H), 7.80–7.71
(m, 2H), 7.53–7.41 (m, 2H), 7.31–7.16 (m, 5H), 7.11–7.00
(m, 2H), 7.88 (d, J=7.14 Hz, 1H), 6.63–6.59 (m, 3H), 5.32–
5.26 (m, 1H), 5.20–5.15 (m, 1H), 5.09–5.01 (m, 1H), 1.65 (s,
3H); 13C NMR (CDCl3, 75 MHz): d=177.45, 143.74, 133.81,
133.72, 132.56, 131.43, 130.72, 129.44, 128.85, 128.45, 128.08,
126.52, 126.29, 125.82, 124.43, 124.31, 123.82, 123.42, 122.95,
109.60, 76.61, 50.40, 42.70, 20.70; HR-MS (EI+): m/z=
422.1635, calcd. for [C27H22N2O3]: 422.1630. The enantiomer-
ic excess was determined by HPLC with an AD-H column
nol:hexane=1:4), 1.0 mLminÀ1
;
tR =10.8 min (minor),
17.6 min (major).
Compound 19: The Michael product was synthesized ac-
cording to the general procedure as colorless oil; overall
yield: 96%. [a]D25: +40.28 (c 1.0, CHCl3); 1H NMR
422
ꢁ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2010, 352, 416 – 424